skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: British Journal Of Haematology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemia
Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemia

O'Brien, Susan ; Rizzieri, David A. ; Vey, Norbert ; Ravandi, Farhad ; Krug, Utz O. ; Sekeres, Mikkael A. ; Dennis, Mike ; Venditti, Adriano ; Berry, Donald A. ; Jacobsen, Tove Flem ; Staudacher, Karin ; Bergeland, Trygve ; Giles, Francis J.

British journal of haematology, 2012-09, Vol.158 (5), p.581-588 [Periódico revisado por pares]

Oxford: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
2
Elacytarabine has single-agent activity in patients 
with advanced acute myeloid leukaemia
Elacytarabine has single-agent activity in patients 
with advanced acute myeloid leukaemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Elacytarabine has single-agent activity in patients 
with advanced acute myeloid leukaemia

O'Brien, Susan ; Rizzieri, David A ; Vey, Norbert ; Ravandi, Farhad ; Krug, Utz O ; Sekeres, Mikkael A ; Dennis, Mike ; Venditti, Adriano ; Berry, Donald A ; Jacobsen, Tove Flem ; Staudacher, Karin ; Bergeland, Trygve ; Giles, Francis J

British Journal of Haematology, 2012-06 [Periódico revisado por pares]

Wiley-Blackwell

Texto completo disponível

Citações Citado por
3
Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002
Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002
Material Type:
Artigo 		Adicionar ao Meu Espaço

Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002

Rizzieri, David A. ; Johnson, Jeffrey L. ; Byrd, John C. ; Lozanski, Gerard ; Blum, Kristie A. ; Powell, Bayard L. ; Shea, Thomas C. ; Nattam, Sreenivasa ; Hoke, Eva ; Cheson, Bruce D. ; Larson, Richard A.

British journal of haematology, 2014-04, Vol.165 (1), p.102-111 [Periódico revisado por pares]

Oxford: Blackwell

Texto completo disponível

Citações Citado por
4
A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma
A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma

Batlevi, Connie L. ; Crump, Michael ; Andreadis, Charalambos ; Rizzieri, David ; Assouline, Sarit E. ; Fox, Susan ; Jagt, Richard H. C. ; Copeland, Amanda ; Potvin, Diane ; Chao, Richard ; Younes, Anas

British journal of haematology, 2017-08, Vol.178 (3), p.434-441 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
5
Autologous haematopoietic cell transplantation for non‐Hodgkin lymphoma with secondary CNS involvement
Autologous haematopoietic cell transplantation for non‐Hodgkin lymphoma with secondary CNS involvement
Material Type:
Artigo 		Adicionar ao Meu Espaço

Autologous haematopoietic cell transplantation for non‐Hodgkin lymphoma with secondary CNS involvement

Maziarz, Richard T. ; Wang, Zhiwei ; Zhang, Mei‐Jie ; Bolwell, Brian J. ; Chen, Andy I. ; Fenske, Timothy S. ; Freytes, Cesar O. ; Gale, Robert P. ; Gibson, John ; Hayes‐Lattin, Brandon M. ; Holmberg, Leona ; Inwards, David J. ; Isola, Luis M. ; Khoury, Hanna J. ; Lewis, Victor A. ; Maharaj, Dipnarine ; Munker, Reinhold ; Phillips, Gordon L. ; Rizzieri, David A. ; Rowlings, Philip A. ; Saber, Wael ; Satwani, Prakash ; Waller, Edmund K. ; Maloney, David G. ; Montoto, Silvia ; Laport, Ginna G. ; Vose, Julie M. ; Lazarus, Hillard M. ; Hari, Parameswaran N.

British journal of haematology, 2013-09, Vol.162 (5), p.648-656 [Periódico revisado por pares]

Oxford: Blackwell

Texto completo disponível

Citações Citado por
6
Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: Cancer and Leukemia Group B study 10002
Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: Cancer and Leukemia Group B study 10002
Material Type:
Artigo 		Adicionar ao Meu Espaço

Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: Cancer and Leukemia Group B study 10002

Rizzieri, David A. ; Johnson, Jeffrey L. ; Byrd, John C. ; Lozanski, Gerard ; Blum, Kristie A. ; Powell, Bayard L. ; Shea, Thomas C. ; Nattam, Sreenivasa ; Hoke, Eva ; Cheson, Bruce D. ; Larson, Richard A.

British journal of haematology, 2014-04, Vol.165 (1), p.102-111 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
7
Dose‐intense chemoimmunotherapy plus radioimmunotherapy in high‐risk diffuse large B‐cell lymphoma and mantle cell lymphoma: a phase II study
Dose‐intense chemoimmunotherapy plus radioimmunotherapy in high‐risk diffuse large B‐cell lymphoma and mantle cell lymphoma: a phase II study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dose‐intense chemoimmunotherapy plus radioimmunotherapy in high‐risk diffuse large B‐cell lymphoma and mantle cell lymphoma: a phase II study

Hudson, Kathryn E. ; Rizzieri, David ; Thomas, Samantha M. ; LeBlanc, Thomas W. ; Powell, Zachary ; Diehl, Louis ; Moore, Joseph O. ; DeCastro, Carlos ; Beaven, Anne W.

British journal of haematology, 2019-02, Vol.184 (4), p.647-650 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
8
Autologous haematopoietic cell transplantation for non‐ H odgkin lymphoma with secondary CNS involvement
Autologous haematopoietic cell transplantation for non‐ H odgkin lymphoma with secondary CNS involvement
Material Type:
Artigo 		Adicionar ao Meu Espaço

Autologous haematopoietic cell transplantation for non‐ H odgkin lymphoma with secondary CNS involvement

Maziarz, Richard T. ; Wang, Zhiwei ; Zhang, Mei‐Jie ; Bolwell, Brian J. ; Chen, Andy I. ; Fenske, Timothy S. ; Freytes, Cesar O. ; Gale, Robert P. ; Gibson, John ; Hayes‐Lattin, Brandon M. ; Holmberg, Leona ; Inwards, David J. ; Isola, Luis M. ; Khoury, Hanna J. ; Lewis, Victor A. ; Maharaj, Dipnarine ; Munker, Reinhold ; Phillips, Gordon L. ; Rizzieri, David A. ; Rowlings, Philip A. ; Saber, Wael ; Satwani, Prakash ; Waller, Edmund K. ; Maloney, David G. ; Montoto, Silvia ; Laport, Ginna G. ; Vose, Julie M. ; Lazarus, Hillard M. ; Hari, Parameswaran N.

British journal of haematology, 2013-09, Vol.162 (5), p.648-656 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
9
Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL)
Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL)

Advani, Anjali S. ; Gibson, Sarah ; Douglas, Elizabeth ; Diacovo, Julia ; Elson, Paul ; Kalaycio, Matt ; Copelan, Ed ; Sekeres, Mikkael ; Sobecks, Ronald ; Sungren, Shawnda ; Lagoo, Anand ; Rizzieri, David ; Hsi, Eric

British journal of haematology, 2011-05, Vol.153 (4), p.504-507 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
10
Thalidomide has limited single‐agent activity in relapsed or refractory indolent non‐Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B
Thalidomide has limited single‐agent activity in relapsed or refractory indolent non‐Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B
Material Type:
Artigo 		Adicionar ao Meu Espaço

Thalidomide has limited single‐agent activity in relapsed or refractory indolent non‐Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B

Smith, Sonali M. ; Grinblatt, David ; Johnson, Jeffrey L. ; Niedzwiecki, Donna ; Rizzieri, David ; Bartlett, Nancy L. ; Cheson, Bruce D.

British journal of haematology, 2008-02, Vol.140 (3), p.313-319 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2003  (10)
  2. 2003Até2006  (16)
  3. 2007Até2010  (19)
  4. 2011Até2015  (36)
  5. Após 2015  (47)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.